Genmab-2026-JPM.pdf

1、 Genmab 2026Leading antibody science for better futures44th Annual J.P.Morgan Healthcare ConferenceJanuary 13,2026 Genmab 2026Forward looking statementThis presentation contains forward looking statements.The words“believe”,“expect”,“anticipate”,“intend”and“plan”and similar expressions identify forw

2、ard looking statements.All statements other than statements of historical facts included in this presentation,including,without limitation,those regarding our financial position,business strategy,plans and objectives of management for future operations(including development plans and objectives rela

3、ting to our products),are forward looking statements.Such forward looking statements involve known and unknown risks,uncertainties and other factors which may cause our actual results,performance or achievements to be materially different from any future results,performance or achievements expressed

4、 or implied by such forward looking statements.Such forward looking statements are based on numerous assumptions regarding our present and future business strategies and the environment in which we will operate in the future.The important factors that could cause our actual results,performance or ac

5、hievements to differ materially from those in the forward looking statements include,among others,risks associated with product discovery and development,uncertainties related to the outcome of clinical trials,slower than expected rates of patient recruitment,unforeseen safety issues resulting from

6、the administration of our products in patients,uncertainties related to product manufacturing,the lack of market acceptance of our products,our inability to manage growth,the competitive environment in relation to our business area and markets,our inability to attract and retain suitably qualified p